Complex Role of MiR-130a-3p and MiR-148a-3p Balance on Drug Resistance and Tumor Biology in Esophageal Squamous Cell Carcinoma

Overview

Journal Sci Rep

Specialty Science

Date 2018 Dec 5

PMID 30510209

Citations 16

Authors

A K Eichelmann

C Matuszcak

K Lindner

J Haier

D J Hussey

R Hummel

Affiliations

Soon will be listed here.

Abstract

miRNAs play a crucial role in cancer development and progression. However, results on the impact of miRNAs on drug sensitivity and tumor biology vary, and most studies to date focussed on either increasing or decreasing miRNA expression levels. Therefore, the current study investigated the role of different expression levels of miR-130a-3p and miR-148a-3p on drug resistance and tumor biology in four esophageal squamous cell carcinoma cell lines. Interestingly, up- and downregulation of both miRNAs significantly increased sensitivity towards chemotherapy. MiRNA modulation also reduced adherence and migration potential, and increased apoptosis rates. Target analyses showed that up- and downregulation of both miRNAs activated the apoptotic p53-pathway via increased expression of either BAX (miR-148a-3p) or Caspase 9 (miR-130a-3p). miR-148a-3p downregulation seemed to mediate its effects primarily via regulation of Bim rather than Bcl-2 levels, whereas we found the opposite scenario following miR-148a-3p upregulation. A similar effect was observed for miR-130a-3p regulating Bcl-2 and XIAP. Our data provide the first evidence that miRNA modulation in both directions may lead to similar effects on chemotherapy response and tumor biology in esophageal squamous cell carcinoma. Most interestingly, up- and downregulation seem to mediate their effects via modulating the balance of several validated or predicted targets.

Citing Articles

MicroRNA-130a-3p regulates osimertinib resistance by targeting runt-related transcription factor 3 in lung adenocarcinoma.

Shintani T, Shun Y, Toyozumi Y, Ikemura K, Shiroyama T, Nagatomo I Sci Rep. 2024; 14(1):24429.

PMID: 39424918 PMC: 11489462. DOI: 10.1038/s41598-024-76196-1.

Role of exosomes in metastasis and therapeutic resistance in esophageal cancer.

Ning X, Ma J, He W, Ma J World J Gastroenterol. 2023; 29(42):5699-5715.

PMID: 38075847 PMC: 10701334. DOI: 10.3748/wjg.v29.i42.5699.

High salt-induced PSI-supercomplex is associated with high CEF and attenuation of state transitions.

Kalra I, Wang X, Zhang R, Morgan-Kiss R Photosynth Res. 2023; 157(2-3):65-84.

PMID: 37347385 PMC: 10484818. DOI: 10.1007/s11120-023-01032-y.

Integrated analysis of coexpression and a tumor-specific ceRNA network revealed a potential prognostic biomarker in breast cancer.

Zheng M, Wu L, Xiao R, Zhou Y, Cai J, Chen W Transl Cancer Res. 2023; 12(4):949-964.

PMID: 37180647 PMC: 10175005. DOI: 10.21037/tcr-23-313.

A cellular regulator of the niche: telocyte.

Babadag S, Celebi-Saltik B Tissue Barriers. 2022; 11(4):2131955.

PMID: 36218299 PMC: 10606812. DOI: 10.1080/21688370.2022.2131955.

References

He M, Xue Y . MicroRNA-148a suppresses proliferation and invasion potential of non-small cell lung carcinomas via regulation of STAT3. Onco Targets Ther. 2017; 10:1353-1361. PMC: 5338933. DOI: 10.2147/OTT.S123518. View

Fujita Y, Kojima T, Kawakami K, Mizutani K, Kato T, Deguchi T . miR-130a activates apoptotic signaling through activation of caspase-8 in taxane-resistant prostate cancer cells. Prostate. 2015; 75(14):1568-78. DOI: 10.1002/pros.23031. View

Sorrentino A, Liu C, Addario A, Peschle C, Scambia G, Ferlini C . Role of microRNAs in drug-resistant ovarian cancer cells. Gynecol Oncol. 2008; 111(3):478-86. DOI: 10.1016/j.ygyno.2008.08.017. View

Li N, Wang H, Yang L, Jia X, Chen C, Wang X . [Regulatory effects and associated mechanisms of miR-130a molecules on cisplatin resistance in ovarian cancer A2780 cell lines]. Sichuan Da Xue Xue Bao Yi Xue Ban. 2014; 44(6):865-70. View

Hummel R, Watson D, Smith C, Kist J, Michael M, Haier J . Mir-148a improves response to chemotherapy in sensitive and resistant oesophageal adenocarcinoma and squamous cell carcinoma cells. J Gastrointest Surg. 2011; 15(3):429-38. DOI: 10.1007/s11605-011-1418-9. View

Liu Y, Li Y, Wang R, Qin S, Liu J, Su F . MiR-130a-3p regulates cell migration and invasion via inhibition of Smad4 in gemcitabine resistant hepatoma cells. J Exp Clin Cancer Res. 2016; 35:19. PMC: 4729098. DOI: 10.1186/s13046-016-0296-0. View

Dai Y, Xie C, Neis J, Fan C, Vural E, Spring P . MicroRNA expression profiles of head and neck squamous cell carcinoma with docetaxel-induced multidrug resistance. Head Neck. 2011; 33(6):786-91. DOI: 10.1002/hed.21540. View

Kim J, Zhang Y, Skalski M, Hayes J, Kefas B, Schiff D . microRNA-148a is a prognostic oncomiR that targets MIG6 and BIM to regulate EGFR and apoptosis in glioblastoma. Cancer Res. 2014; 74(5):1541-53. PMC: 3947487. DOI: 10.1158/0008-5472.CAN-13-1449. View

Zhu X, Zhao H, Lin Z, Zhang G . Functional studies of miR-130a on the inhibitory pathways of apoptosis in patients with chronic myeloid leukemia. Cancer Gene Ther. 2015; 22(12):573-80. DOI: 10.1038/cgt.2015.50. View

10.

Ouyang M, Li Y, Ye S, Ma J, Lu L, Lv W . MicroRNA profiling implies new markers of chemoresistance of triple-negative breast cancer. PLoS One. 2014; 9(5):e96228. PMC: 4008525. DOI: 10.1371/journal.pone.0096228. View

11.

Lakshmipathy U, Hart R . Concise review: MicroRNA expression in multipotent mesenchymal stromal cells. Stem Cells. 2007; 26(2):356-63. PMC: 2673465. DOI: 10.1634/stemcells.2007-0625. View

12.

Jiang H, Yu W, Wang L, Peng Y . miR-130a acts as a potential diagnostic biomarker and promotes gastric cancer migration, invasion and proliferation by targeting RUNX3. Oncol Rep. 2015; 34(3):1153-61. PMC: 4530930. DOI: 10.3892/or.2015.4099. View

13.

Kim V . MicroRNA biogenesis: coordinated cropping and dicing. Nat Rev Mol Cell Biol. 2005; 6(5):376-85. DOI: 10.1038/nrm1644. View

14.

Matuszcak C, Lindner K, Eichelmann A, Hussey D, Haier J, Hummel R . microRNAs: Key regulators of chemotherapy response and metastatic potential via complex control of target pathways in esophageal adenocarcinoma. Surg Oncol. 2018; 27(3):392-401. DOI: 10.1016/j.suronc.2018.04.001. View

15.

Ambros V . MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing. Cell. 2003; 113(6):673-6. DOI: 10.1016/s0092-8674(03)00428-8. View

16.

Murata T, Takayama K, Katayama S, Urano T, Horie-Inoue K, Ikeda K . miR-148a is an androgen-responsive microRNA that promotes LNCaP prostate cell growth by repressing its target CAND1 expression. Prostate Cancer Prostatic Dis. 2010; 13(4):356-61. DOI: 10.1038/pcan.2010.32. View

17.

Duan J, Zhang H, Qu Y, Deng T, Huang D, Liu R . Onco-miR-130 promotes cell proliferation and migration by targeting TGFβR2 in gastric cancer. Oncotarget. 2016; 7(28):44522-44533. PMC: 5190115. DOI: 10.18632/oncotarget.9936. View

18.

Jin H, Gonzalez-Martin A, Miletic A, Lai M, Knight S, Sabouri-Ghomi M . Transfection of microRNA Mimics Should Be Used with Caution. Front Genet. 2015; 6:340. PMC: 4667072. DOI: 10.3389/fgene.2015.00340. View

19.

Wang H, Pan J, Luo L, Ning X, Ye Z, Yu Z . NF-κB induces miR-148a to sustain TGF-β/Smad signaling activation in glioblastoma. Mol Cancer. 2015; 14:2. PMC: 4429406. DOI: 10.1186/1476-4598-14-2. View

20.

Guo Z, Maki M, Ding R, Yang Y, Zhang B, Xiong L . Genome-wide survey of tissue-specific microRNA and transcription factor regulatory networks in 12 tissues. Sci Rep. 2014; 4:5150. PMC: 5381490. DOI: 10.1038/srep05150. View